A Study on the Analysis of China's Telemedicine Industry from the Perspective of the Industrial Innovation System and its Implications for Korea

Mikyung Kim, Yi ZhangThe Journal of the Korea Contents Association 2021 · DOI

Abstract

This paper investigates the divergent development paths of the telemedicine industries in China and South Korea. While China has experienced explosive growth by leveraging a "Window of Opportunity" in digital technology, South Korea remains hindered by regulatory and institutional barriers. Using the Sectoral Innovation System (SIS) framework, we analyze the key success factors in the Chinese model—including policy agility, technological convergence, and demand-driven innovation—to provide strategic recommendations for revitalizing Korea's digital healthcare sector.

Introduction

The global shift toward "untact" (contactless) healthcare, accelerated by the COVID-19 pandemic, has highlighted a significant disparity between South Korea and China. Despite possessing world-class IT infrastructure, South Korea is caught in a "Winner's Trap," where its previous success in traditional healthcare delivery creates path dependency and resistance to telemedicine. In contrast, China has transitioned from simple hospital-to-hospital (B2B) remote consultations to a robust doctor-to-patient (B2C) ecosystem. This study seeks to understand the structural reasons for this divergence and extract actionable insights for the Korean context.

Methods: The Sectoral Innovation System (SIS)

The researchers employ the Sectoral Innovation System (SIS) framework to analyze the telemedicine industry as a specific regime. Unlike aggregate economic analyses, SIS focuses on the interplay between knowledge, actors, and institutions within a single sector.

SIS Analytical Framework

The analysis breaks the sector down into six key dimensions: Knowledge & Technology, Actors, Networks, Institutions, Demand Conditions, and Windows of Opportunity. This framework allows for a holistic view of how technological paradigm shifts can be leveraged by latecomers to leapfrog established leaders.

Key Results and Insights

China's telemedicine market has demonstrated remarkable growth, particularly following the 2014 establishment of the "Online Hospital" model. This marked a critical shift from B2B to B2C healthcare delivery.

Growth of China's Telemedicine Market (2012-2017)

As shown in the market data, China’s telemedicine sector grew by 51% in 2016 alone, reaching approximately 6.15 billion yuan. This growth was driven by the "Leapfrog Effect," where China bypassed legacy analog systems to adopt mobile-first "Internet Hospitals." A primary driver was "necessity-based" demand; the severe shortage of quality medical care in rural areas forced rapid regulatory relaxation and the integration of telemedicine into national infrastructure like the "13th Five-Year Plan."

In contrast, Korea remains bogged down by conflicts between medical associations and the government. The authors suggest that Korea is suffering from a "path dependency" that makes it resistant to the disruptive nature of telemedicine, despite the clear technological readiness of the nation.

Discussion and Strategic Implications

To overcome the current deadlock, the study proposes several strategic shifts for South Korea:

  • Public Demand Surveys: The government should conduct large-scale surveys to demonstrate public demand, moving past the current stalemate with professional associations.
  • Standardization and Infrastructure: Korea needs a unified, standardized medical information system that integrates data from smart wearables with offline clinical records.
  • Regulatory Agility: Following the Chinese example, telemedicine should be treated as a core component of national infrastructure rather than a niche service.

While this study highlights the structural successes of China, it acknowledges the socio-political differences between China's top-down approach and Korea's democratic system. Future research should involve quantitative simulations of the expected effects of telemedicine to provide the empirical evidence necessary for regulatory reform.

Summary updated

BibTeX
@article{kim2021study,
  author = {Mikyung Kim and Yi Zhang},
  title = {{A Study on the Analysis of China's Telemedicine Industry from the Perspective of the Industrial Innovation System and its Implications for Korea}},
  journal = {The Journal of the Korea Contents Association},
  year = {2021},
  doi = {10.5392/jkca.2021.21.03.441},
}
Figure